dental pricing/margin compress acut
focu dental margin y/i take
aggress approach share gain notabl
hsic/xray/dhr recoveri execut cost
base restructur refin commerci pt
guidanc achiev dental price potenti cost
restructur key variabl discrep improv top-
line weaker margin suggest cede price take market share
part dso custom segment focus
respond realiti market greater price transpar
histor posit premium price/product dealer tie
independ practic support margin dso acceler
acquir smaller practic emerg price transpar on-line
co-op dealer demand adapt upsid stabil
sale forc erp resolut give manag bandwidth engag
cost reduct program given top-lin beat guidanc msd
organ growth look achiev forecast organ
growth year revis ep guidanc also appear
within reach appear assum ebit margin declin y/i
in-lin trail trend vs prior guidanc flat ebit margin
face greater price pressur outlin think broader
environ elast market consolid unavoid
highlight conf call ebit margin quarter
y/i surpris come unexpect gm pressur includ
inventori revalu price pressur expect
continu privat label strateg sourc increasingli point
strateg interest management seek off-set gm pressur dental ah
management evalu new cost ration program detail yet avail
trade a/r facil drove cash quarter drive much
enabl pay debt net
debt/ebitda ex-stock-comp end manag
will go right opportun also remain
commit dividend pay-out look potenti buyback
similar opex sale moder year
level
summari model chang revis ep estim goe lower
medic technolog unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
dental ebit margin declin anoth overal though
moder year declin exhibit price
target decreas reflect lower forecast base
yield impli price-to-earnings bear case price
competit distributor escal dental margin deterior
would drive ep lower pt base
yield impli price-to-earnings
organ growth acceler driven greater expect stabil
dental busi stabl share high margin area cerec
block margin improv faster expect anim health reach
ebit margin target tax reform drive corpor tax rate
multipl expand toward averag
pt base yield estim dental
busi organ growth rang anim health rang
combin normal organ growth margin remain pressur
on-going custom consolid e-commerc competit creat
price/mix headwind impli multipl contract price-to-earnings current
price-to-earnings ntm ep
competit heat distributor amzn/discount e-commerc
player take price core dental consum market na
dental companion anim pharma product north american
anim drive organ growth weaker
macroeconom environ combin channel shift toward online/retail
greater gener rx penetr weaker meat demand pressur anim
sale multipl move toward pharma distributor group
larg north american-bas
distributor dental anim health
product fragment consolid
custom base independ
believ like lose share
competitor dental product categori
cerec consum well
appreci market less well
appreci also lose share
anim health structur pressur
converg industri pressur
growth margin
open north american dental
equip distribut drive
dental margin declin due
over-concentr competit us
market anim health margin
de-lever balanc sheet net
capit sale effici
greater use privat label product
risk achiev price
dental util slow medicaid
on-line competit enter market later
expect
erp roll-out creat greater expect
disrupt greater expect upsid
note organ adjust agency/net-gross switch
guidanc
exhibit chang forecast
sale
sale
sale
sale
sale
sale
million except ep
acquisit impact
incom exp
compani data morgan stanley research
morgan stanley research thomson reuter
morgan stanley research thomson reuter
morgan stanley research thomson reuter
morgan stanley research thomson reuter
price target patterson base yield estim
forecast dental busi organ growth rang anim health
rang combin normal organ growth margin remain pressur
on-going custom consolid e-commerc competit creat price/mix
headwind impli multipl ep current
risk price target includ macroeconom environ weaken impact
custom spend meat product demand soften commod price increas
reduc product anim market growth on-line competit enter market
earlier expect erp roll-out creat greater expect disrupt
greater expect upsid wc benefit
incom expens
incom tax
net continu op
revenu
ep continu oper
acquisit impact
equip softwar revenu
acquisit impact
acquisit impact
acquisit impact
acquisit impact
equip softwar revenu
acquisit impact
acquisit impact
acquisit impact
total revenu
acquisit impact
